Lv1
82 积分 2025-11-05 加入
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
24天前
已完结
α2,6-Sialoglycan-regulated antitumor immunity of tumor-infiltrating CD8+ T cells
1个月前
已完结
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy–Naïve Localized Prostate Cancer
1个月前
已完结
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment
1个月前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
3个月前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
3个月前
已完结
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
5个月前
已完结
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
5个月前
已完结
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
6个月前
已完结
Osimertinib activates a TGF-β2–dependent secretory program that drives lung adenocarcinoma progression
6个月前
已完结
皖公网安备34019202002308
